Cervical cancer screening is a vital preventive measure that significantly reduces mortality through early detection of pre-cancerous lesions. Physicians should be familiar with current guidelines recommending HPV testing alone or in combination with Pap smear (co-testing) for women aged 30–65, and Pap smear alone starting from age 21. High-risk human papillomavirus (HPV) types are the primary cause of cervical cancer, making HPV testing a crucial tool. Timely screening, follow-up of abnormal results, and patient counseling on HPV vaccination are essential components of comprehensive care. Physicians must also be aware of screening modifications for immunocompromised individuals or those with prior cervical pathology.
Senior Consultant Gynecology Cancer Surgeon, Global Hospitals, Ahmedabad
Comments
Comments
You must be logged in to leave a comment.